INTERNATIONAL PATENT: NOVARTIS AG FILES APPLICATION FOR "USES OF A CDK2 INHIBITOR IN THE TREATMENT OF CANCER"

GENEVA, Feb. 23 -- NOVARTIS AG (Lichtstrasse 354056 Basel) filed a patent application (PCT/IB2025/058143) for "USES OF A CDK2 INHIBITOR IN THE TREATMENT OF CANCER" on Aug 11, 2025. With publication no. WO/2026/038121, the details related to the patent application was published on Feb 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HO, Samuel Kin Sang (Novartis Institutes for BioMedical Research, Inc.250 Massachusetts AvenueCambridge, Massachusetts 02139), MAERTENS, Ophelia (Novartis Institutes for Biomedical Research Inc.250 Massachusetts AvenueCambridge, Massachusetts 02139), OTERO, Jav...